Evidence map›Paper›PMID 37185437›Full record

ArticleCurrent oncology (Toronto, Ont.)2023

Clinical Rationale of Using Steerable Technologies for Radiofrequency Ablation Followed by Cavity Creation and Cement Augmentation in the Treatment of Painful Spinal Metastases.

Claudio Pusceddu, Salvatore Marsico, Daniele Derudas, Nicola Ballicu, Luca Melis, Stefano Zedda, Carlo De Felice, Alessandro Calabrese, Domiziana Santucci, Eliodoro Faiella

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Claudio PuscedduDepartment of Oncological and Interventional Radiology, Businco Hospital, 09121 Cagliari, Italy.ORCID 0000-0002-3029-990X
Salvatore MarsicoDepartment of Radiology, Hospital del Mar, 08003 Barcelona, Spain.ORCID 0000-0001-9252-3623
Daniele DerudasDepartment of Hematology, Businco Hospital, 09121 Cagliari, Italy.ORCID 0000-0002-0997-4157
Nicola BallicuDepartment of Oncological and Interventional Radiology, Businco Hospital, 09121 Cagliari, Italy.
Luca MelisNuclear Medicine Department, Businco Hospital, 09121 Cagliari, Italy.
Stefano ZeddaDepartment of Oncological and Interventional Radiology, Businco Hospital, 09121 Cagliari, Italy.
Carlo De FeliceDepartment of Radiological Sciences, Oncology and Pathology, Umberto I Hospital, Sapienza University of Rome, Viale del Policlinico 105, 00161 Rome, Italy.
Alessandro CalabreseDepartment of Radiological Sciences, Oncology and Pathology, Umberto I Hospital, Sapienza University of Rome, Viale del Policlinico 105, 00161 Rome, Italy.
Domiziana SantucciDepartment of Radiology, University of Rome "Campus Bio-Medico", Via Alvaro del Portillo, 21, 00128 Rome, Italy.
Eliodoro FaiellaDepartment of Radiology, University of Rome "Campus Bio-Medico", Via Alvaro del Portillo, 21, 00128 Rome, Italy.
Policlinico Umberto I · ITUniversità Campus Bio-Medico · ITHospital Del Mar · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Cement distribution after radiofrequency ablation of spinal metastases can be unpredictable due to various tumor factors, and vertebral augmentation requires advanced devices to prevent cement leakage and achieve satisfactory filling. The purpose of this study is to evaluate the safety and efficacy of a platform of steerable technologies with an articulating radiofrequency ablation (RFA) probe and targeted cavity creation before vertebral augmentation in the treatment of painful spinal metastases. (2) Methods: Sixteen patients (mean age, 67 years) underwent RFA in conjunction with vertebral augmentation after the creation of a targeted balloon cavity for metastatic spinal disease and were followed up to 6 months. Pain and functional mobility were assessed before treatment and postoperatively using the Visual Analogue Score (VAS) and Functional Mobility Scale (FMS). Complications, predictability of cement distribution, anatomical restoration, and local recurrence were collected. Technical success was defined as successful intraoperative ablation and predictable cement distribution after cavity creation without major complications. (3) Results: Sixteen patients with 21 lesions were treated for tumors involving the thoracolumbar spine. All treatments were technically successful and were followed by targeted cavity creation and vertebral augmentation. A statistically significant reduction in median VAS score was observed before treatment and 1 week after RFA treatment (

Indexed as

Catheter AblationRadiofrequency AblationSpinal NeoplasmsAgedHumansPainQuality of Lifequality of liferadiofrequency ablation: spinal metastasesvertebral augmentation

Identifiers

PMID37185437
PMCPMC10136743
OpenAlexW4366414646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.